Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shruti Kahol

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Experimental Cell Research|September 13, 2020
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancerSheikh Mohammad Umar, Akanksha Kashyap, Shruti Kahol, et al.
Technology in Cancer Research & Treatment|February 17, 2026
β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939Sheikh Mohammad Umar, Shruti Kahol, Sandeep R Mathur, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Experimental Cell Research|September 13, 2020
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancerSheikh Mohammad Umar, Akanksha Kashyap, Shruti Kahol, et al.
Technology in Cancer Research & Treatment|February 17, 2026
β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939Sheikh Mohammad Umar, Shruti Kahol, Sandeep R Mathur, et al.
Pageof 1